VVT Medical Featured in TSXgpt Interview: Discussing Pain-Free Innovation in $60B Vein Care Market

Written By Jeff Maser

VVT Med Inc. (TSXV: VVTM), was recently featured in an interview with TSXgpt, where CEO Erez Tetro discussed the Company's innovative approach to addressing the rapidly expanding global vein-care market.

Please see the full interview below.

Jeff Maser
Next

VVT Med Announces Acceptance of Procedure Fee for ScleroSafe® in South Korea